OMEC.AI's mission is to help pharmaceutical companies have better chances in clinical trials by making better data-driven decisions in the pre-clinical process.

The company provides an automated, data-focused solution that can produce a reliable assessment of the clinical trial-readiness of a proposed drug.OMEC.AI was established with funding and support from AION Labs, a collaboration between pharmaceutical giants Pfizer, AstraZeneca, Merck, and Teva Pharmaceuticals, together with Amazon's AWS and the Israel Biotech Fund.